Cargando…
Harnessing Unconventional T Cells and Innate Lymphoid Cells to Prevent and Treat Hematological Malignancies: Prospects for New Immunotherapy
Unconventional T cells and innate lymphoid cells (ILCs) make up a heterogeneous set of cells that characteristically show prompt responses toward specific antigens. Unconventional T cells recognize non-peptide antigens, which are bound and presented by diverse non-polymorphic antigen-presenting mole...
Autores principales: | Allegra, Alessandro, Casciaro, Marco, Lo Presti, Elena, Musolino, Caterina, Gangemi, Sebastiano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221132/ https://www.ncbi.nlm.nih.gov/pubmed/35740879 http://dx.doi.org/10.3390/biom12060754 |
Ejemplares similares
-
Exosome-Mediated Therapeutic Strategies for Management of Solid and Hematological Malignancies
por: Allegra, Alessandro, et al.
Publicado: (2022) -
The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox
por: Allegra, Alessandro, et al.
Publicado: (2019) -
Epigenetic Crosstalk between Malignant Plasma Cells and the Tumour Microenvironment in Multiple Myeloma
por: Allegra, Alessandro, et al.
Publicado: (2022) -
IL-31, itch and hematological malignancies
por: Di Salvo, Eleonora, et al.
Publicado: (2021) -
Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia
por: Allegra, Alessandro, et al.
Publicado: (2021)